Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/18/15
End: 12/28/16
Due: 12/28/17
Phase: N/A
Priority: Normal
Start: 04/08/15
End: 05/24/17
Due: 05/24/18
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study of Safety and Tolerability of VLX600, an Iron Chelator, in Patients With Refractory Advanced Solid Tumors | NCT02222363 | Vivolux AB | user2@example.com | None | 2015-02-18 | 2016-12-28 | 2017-12-28 | - | - | 2025-07-14 |
| A Study of VLX1570 and Dexamethasone in Myeloma Patients | NCT02372240 | Vivolux AB | user2@example.com | None | 2015-04-08 | 2017-05-24 | 2018-05-24 | - | - | 2025-07-14 |